ARG70361
SARS-CoV-2 Nucleocapsid recombinant protein (Omicron B1.1.529 Variant) (Tag Free)
SARS-CoV-2 Nucleocapsid recombinant protein (Omicron B1.1.529 Variant) (Tag Free) for SDS-PAGE and Virus
Overview
| Product Description | E. coli expressed recombinant SARS-CoV-2 Nucleocapsid protein (Omicron B1.1.529 Variant) |
|---|---|
| Tested Reactivity | Virus |
| Tested Application | SDS-PAGE |
| Target Name | SARS-CoV-2 Nucleocapsid protein (Omicron) |
| Species | Virus |
| A.A. Sequence | MSDNG PQNQR NALRI TFGGP SDSTG SNQNG GARSK QRRPQ GLPNN TASWF TALTQ HGKED LKFPR GQGVP INTNS SPDDQ IGYYR RATRR IRGGD GKMKD LSPRWY FYYLG TGPEA GLPYG ANKDG IIWVA TEGAL NTPKD HIGTR NPANN AAIVL QLPQG TTLPK GFYAE GSRGG SQASS RSSSR SRNSS RNSTP GSSKR TSPAR MAGNG GDAAL ALLLL DRLNQ LESKM SGKGQ QQQGQ TVTKK SAAEA SKKPR QKRTA TKAYN VTQAF GRRGP EQTQG NFGDQ ELIRQ GTDYK HWPQI AQFAP SASAF FGMSR IGMEV TPSGT WLTYT GAIKL DDKDP NFKDQ VILLN KHIDA YKTFP PTEPK KDKKK KADET QALPQ RQKKQ QTVTL LPAAD LDDFS KQLQQ SMSSA DSTQA. |
| Expression System | E. coli |
Properties
| Form | Powder |
|---|---|
| Purification | Purified by chromatography. |
| Purification Note | Endotoxin level is less than 0.1 EU/µg of the protein, as determined by the LAL test. |
| Purity | >90% as determined by SDS-PAGE analysis. |
| Buffer | PBS (pH 7.4) and 0.5 M NaCl. |
| Reconstitution | It is recommended to reconstitute the lyophilized protein in sterile water to a concentration not less than 100 µg/ml and incubate the stock solution for at least 20 min at room temperature to make sure the protein is dissolved completely. |
| Storage Instruction | Lyophilized protein should be stored at -20°C. After reconstitution, aliquot and store at -20°C or -80°C for up to one month. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. |
| Note | For laboratory research only, not for drug, diagnostic or other use. |
Bioinformation
| Highlight | Related products: SARS-CoV antibodies; SARS-CoV ELISA Kits; SARS-CoV recombinant proteins; Related news: HMGB1, a biomarker and therapeutic target in COVID-19 Exploring Antiviral Immune Response |
|---|
